Publications dans lesquelles il/elle collabore avec IÑAKI MILTON LASKIBAR (49)

2024

  1. Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats

    BioFactors

  2. Microbiota y nutrición personalizada

    Nutrición y dietética: de la teoría a la práctica (Ediciones Eunate), pp. 429-438

  3. Physiological responses and microbiota shifts after spermidine administration as a postbiotic on rodents fed a high-fat high-fructose diet

    Beneficial Microbes, Vol. 15, Núm. 5, pp. 515-525

2023

  1. Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats

    Antioxidants, Vol. 12, Núm. 3

  2. Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations

    Nutrients, Vol. 15, Núm. 4

  3. Features of Non-Alcoholic Beer on Cardiovascular Biomarkers. Can It Be a Substitute for Conventional Beer?

    Nutrients, Vol. 15, Núm. 1

  4. Lactobacillus rhamnosus GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic

    Food and Function, Vol. 14, Núm. 19, pp. 8865-8875

  5. Oral administration of viable or heat-inactivated Lacticaseibacillus rhamnosus GG influences on metabolic outcomes and gut microbiota in rodents fed a high-fat high-fructose diet

    Journal of Functional Foods, Vol. 109

  6. Potential usefulness of Mediterranean diet polyphenols against COVID-19-induced inflammation: a review of the current knowledge

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 2, pp. 371-382

  7. Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes

    Frontiers in Nutrition, Vol. 9

2022

  1. Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae

    Biomedicines, Vol. 10, Núm. 8

  2. Konposatu fenolikoak eta hesteko mikrobiota: Amodio eta gorrotozko istorio bat

    Elhuyar: zientzia eta teknika, Núm. 347, pp. 82-85

  3. Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

2021

  1. Adipogenesia, osasunaren etsai edo lagun?

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 39, pp. 11-21

  2. Current knowledge on beetroot bioactive compounds: Role of nitrate and betalains in health and disease

    Foods, Vol. 10, Núm. 6

  3. Effects of pterostilbene on diabetes, liver steatosis and serum lipids

    Current Medicinal Chemistry, Vol. 28, Núm. 2, pp. 238-252

  4. Fruktosaren kontsumoak eragin ditzakeen osasun arazoak: konponbidea arazo bihurtzen denean

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 41, pp. 109-126

  5. Precision nutrition based on phenotypical traits and the (epi)genotype: nutrigenetic and nutrigenomic approaches for obesity care

    Current opinion in clinical nutrition and metabolic care, Vol. 24, Núm. 4, pp. 315-325

  6. Probióticos, parabióticos y postbióticos en la prevención y tratamiento de alteraciones de la salud relacionadas con el síndrome metabólico

    Revista española de nutrición humana y dietética, Vol. 25, Núm. 3, pp. 32-33

  7. Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: A comparison with its analog resveratrol

    Food and Function, Vol. 12, Núm. 7, pp. 3266-3279